S. 2658 · Senate bill · 119th Congress
Medication Affordability and Patent Integrity Act Introduced Aug 1, 2025 Reported by committee Jul 28, 2026 Passed the Senate (not yet) Passed the House (not yet) Law (not yet) Latest action, Jul 28, 2026 : Placed on Senate Legislative Calendar under General Orders. Calendar No. 528.
What it would change (4) About this text
4 sections of the Code · 12 changes asked for
Text: reported in Senate Reported The text a committee sent back to its chamber, often with changes, recommending a vote. , Jul 28, 2026
The other version Official text on Congress.gov
Written by AIWhat this bill would change in the Code
Drug and biologic makers who apply for FDA approval or hold approved applications or licenses would have to certify to the FDA that their patent-related information matches what they told the Patent and Trademark Office. They would also have to send the Patent Office the patent-relevant information they gave the FDA, plus the FDA's responses, and certify it is complete. The duties would apply to new applications after enactment and only in part to earlier ones. Trade-secret protection would carry over, except what the Office finds the public needs to understand the patent. Failing to submit the certification would become a prohibited act. Someone accused of infringing a drug or biologic patent could use a new defense if the patent's owner, or a previous owner, negligently or intentionally failed to make these disclosures. The defense would not be open to a covered foreign person.
Summed up from the notes on the 4 sections the bill would change. It covers only changes to the Code. No person has checked it, and it can be wrong. The changes themselves are what the bill would do. About these notes
Sections are cited like “7 U.S.C. § 2012”: title Title One of the 54 subject areas the Code is divided into, such as Title 7 (Agriculture) or Title 26 (taxes). A title is split into chapters. 7 of the United States Code U.S.C. (United States Code) The United States Code: the federal laws in force, arranged by subject. "4 U.S.C. § 8" means title 4, section 8. , section Section (§) The basic unit of the Code, marked §. Each section has a number within its title and is cited like "7 U.S.C. § 2012". 2012.
21 U.S.C. Chapter 9 · Federal Food, Drug, and Cosmetic Act 2 sections § 331 Prohibited acts 1 of 3 shown § 355 New drugs Shown 35 U.S.C. Chapter 28 · Infringement of Patents 1 section § 274 Non-disclosure defense to infringement of drug patent New Shown 42 U.S.C. Chapter 6A · Public Health Service 1 section § 262 Regulation of biological products Shown